BACKGROUNDThe prevalence of Methicillin-resistant Staphylococcus aureus (MRSA) is increasing worldwide and is a growing public health concern. Serious infections due to Staphylococcus aureus and especially due to Methicillin-resistant Staphylococcus aureus has become a major clinical challenge.The present study was planned to determine the prevalence of Methicillin-resistant Staphylococcus aureus (MRSA) from clinical specimens and to determine their antibiotic susceptibility pattern.
MATERIALS AND METHODSThe study was carried out in the Department of Microbiology, JNIMS, Manipur, from the year 2016 to 2017. A total of 770 Staphylococcus aureus strains were isolated from clinical specimens like urine, pus, blood, sputum, etc. All strains were identified by standard microbiological techniques. S. aureus strains were subsequently tested for Methicillin resistance by using Cefoxitin discs. The antibiotic susceptibility pattern of all the MRSA strains identified was determined by Kirby-Bauer disc diffusion method.
RESULTSA total number of 770 S. aureus was isolated, of which 560 were MRSA. The prevalence of MRSA was different among various clinical specimens with maximum seen in urinary isolates (88.4%) followed by pus (79.6%). All the 560 MRSA strains were found to be resistant to Penicillin (100%); 76.9% to Gentamicin, 73.5% to Amikacin, 74.1% to Erythromycin, 69.2% to Cotrimoxazole, 77.7% to Ciprofloxacin and 60.9% to Tetracycline. MRSA strains were resistant to ≥ 8.0 drugs, multidrug resistance. Sensitivity to Linezolid and Vancomycin was seen. A few (3/560) Vancomycin intermediate Staphylococcus aureus (VISA) strains were identified by E-test.
CONCLUSIONHigh rate of prevalence of MRSA with multidrug resistance of MRSA towards commonly used antibiotics was observed. Linezolid was the only antibiotic found to give uniform sensitivity (100%). A few VISA strains were identified. The findings highlight the importance of in vitro susceptibility testing of every isolate of MRSA in clinical laboratories.